Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 06, 2026
TickeronGET DAILY SIGNALS
Why Is Tempus AI (TEM) Stock Down -8.99% Today?

Why Is Tempus AI (TEM) Stock Down -8.99% Today?

Key Takeaways

  • Tempus AI shares fell roughly 9% intraday, pulling back to about $76.04 from a prior close of $83.55.
  • The decline largely unwound the prior session's 9% surge driven by an FDA clearance and a bullish analyst call.
  • Insider selling — CEO and founder Eric Lefkofsky has sold more than 1 million shares since mid-September — weighed on sentiment.
  • Bearish options positioning and broad profit-taking in high-momentum AI names added to the pressure.
  • Traders are now watching whether the stock can hold above its recent breakout levels and the timing of the next earnings report.

Opening Summary

TEM, or Tempus AI, Inc., is a healthcare technology company that uses artificial intelligence and multimodal clinical data to power precision medicine, offering genomic diagnostics and data-licensing services to clinicians and pharmaceutical partners. In today's session, TEM traded down approximately 8.99% to $76.04, compared with a previous close of $83.55. The move marked a sharp reversal of the prior day's rally, as markets digested heavy insider selling and took profits following a recent run-up.

Profit-Taking After a Sharp Rally

The decline came on the heels of a powerful prior-session advance, when TEM jumped about 9% after the company received FDA 510(k) clearance for Tempus ECG-MR, an AI tool that flags possible mitral regurgitation from standard ECG readings, and after Guggenheim raised its price target on the stock. Such outsized single-day gains frequently invite profit-taking the following session, and today's reversal returned the shares to roughly the level where they traded before the clearance-driven pop. The giveback suggests that near-term traders locked in gains rather than any deterioration in the company's fundamentals.

Insider Selling Weighs on Sentiment

Investor attention also turned to ongoing insider transactions. Founder, chairman, and CEO Eric Lefkofsky has sold more than 1 million Class A shares across multiple trades since mid-September, at prices between roughly $76 and $81. While routine executive selling can be part of pre-planned diversification, the scale and timing of the disposals — coming as the stock sat near its recent highs — were cited by market participants as a negative signal that pressured TEM shares.

Bearish Options Activity and Momentum Rotation

Adding to the selling pressure were signs of cautious positioning in the options market, where traders were reported to have sold far out-of-the-money calls while buying out-of-the-money puts in late August, reflecting limited conviction in further upside. The stock, which carries a notably high beta and has been a favorite among high-momentum AI investors, was also caught up in broader rotation away from speculative growth names in the session, amplifying its move relative to the broader market.

Market Context and Trading Activity

The pullback in TEM was more pronounced than the broader tape, underscoring the stock-specific and momentum-driven nature of the decline. Trading volume was elevated as the session progressed, consistent with active repositioning following the prior day's breakout. The reversal brought the shares back toward a zone that several sell-side analysts have flagged as near fair value — a number of recently initiated or updated ratings carry price objectives at or below the stock's pre-decline levels — reinforcing the notion that valuation itself became a source of resistance after the rapid climb.

What Comes Next for TEM

Looking ahead, investors will watch whether TEM can hold key technical support and whether the pullback stabilizes or extends. The company's next quarterly earnings report is a key near-term catalyst, along with progress on reimbursement expansion for its diagnostics portfolio, the integration of its planned Personalis acquisition, and upcoming renewals of major data-licensing contracts. Risks include continued insider selling, the company's still-negative profitability, and the sensitivity of a high-multiple growth stock to shifting risk appetite in the AI sector.

Trending AI Robots

For investors seeking a more systematic approach to navigating fast-moving names like TEM, Tickeron's Trending AI Robots page offers a curated look at the platform's strongest-performing AI trading bots. Tickeron hosts hundreds of bots covering thousands of tickers, each varying by strategy, timeframe, performance metrics, and traded symbols. Only the bots demonstrating the best results under current market conditions are featured in this section, helping traders quickly identify approaches that are working right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TEM

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


TEM sees MACD Histogram just turned negative

TEM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 23 instances where the indicator turned negative. In 21 of the 23 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TEM as a result. In 29 of 37 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

TEM moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TEM crossed bearishly below the 50-day moving average on November 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TEM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for TEM entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +19.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where TEM advanced for three days, in 117 of 132 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

TEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TEM's P/B Ratio (31.032) is slightly higher than the industry average of (4.523). TEM has a moderately low P/E Ratio (-52.812) as compared to the industry average of (12.601). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.536). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (8.696) is also within normal values, averaging (6.105).

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. TEM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TEM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 3.31B. The market cap for tickers in the group ranges from 708 to 49.18B. VEEV holds the highest valuation in this group at 49.18B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -13%. For the same Industry, the average monthly price growth was -13%, and the average quarterly price growth was 2%. PRVA experienced the highest price growth at 4%, while BFRG experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 27%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 53
Price Growth Rating: 56
SMR Rating: 86
Profit Risk Rating: 97
Seasonality Score: 0 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Industry
N/A
Address
600 West Chicago Avenue
Phone
+1 800 976-5448
Employees
3800
Web
https://www.tempus.com
Interact to see
Advertisement
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.